Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: A randomized, double-blind, placebo-controlled trial.
Ramakrishnan N, Lijffijt M, Green CE, Balderston NL, Murphy N, Grillon C, Iqbal T, Vo-Le B, O'Brien B, Murrough JW, Swann AC, Mathew SJ. Ramakrishnan N, et al. Depress Anxiety. 2021 Nov;38(11):1108-1119. doi: 10.1002/da.23194. Epub 2021 Jul 12. Depress Anxiety. 2021. PMID: 34254405 Free PMC article. Clinical Trial.
A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-D-aspartate receptor blockade in healthy veterans.
Murphy N, Ramakrishnan N, Vo-Le B, Vo-Le B, Smith MA, Iqbal T, Swann AC, Mathew SJ, Lijffijt M. Murphy N, et al. Among authors: ramakrishnan n. Neuropsychopharmacology. 2021 Mar;46(4):820-827. doi: 10.1038/s41386-020-00917-z. Epub 2020 Dec 14. Neuropsychopharmacology. 2021. PMID: 33318635 Free PMC article. Clinical Trial.
Distinct trajectories of antidepressant response to intravenous ketamine.
O'Brien B, Lijffijt M, Lee J, Kim YS, Wells A, Murphy N, Ramakrishnan N, Swann AC, Mathew SJ. O'Brien B, et al. Among authors: ramakrishnan n. J Affect Disord. 2021 May 1;286:320-329. doi: 10.1016/j.jad.2021.03.006. Epub 2021 Mar 9. J Affect Disord. 2021. PMID: 33770540
Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.
Lijffijt M, Murphy N, Iqbal S, Green CE, Iqbal T, Chang LC, Haile CN, Hirsch LC, Ramakrishnan N, Fall DA, Swann AC, Al Jurdi RK, Mathew SJ. Lijffijt M, et al. Among authors: ramakrishnan n. Neuropsychopharmacology. 2022 Apr;47(5):1088-1095. doi: 10.1038/s41386-021-01242-9. Epub 2021 Nov 27. Neuropsychopharmacology. 2022. PMID: 34839364 Free PMC article. Clinical Trial.
Neurophysiological Effect of Ketamine on Prefrontal Cortex in Treatment-Resistant Depression: A Combined Transcranial Magnetic Stimulation-Electroencephalography Study.
Ramakrishnan N, Murphy NRE, Walker CP, Cuellar Leal VA, Soares JC, Cho RYJ, Selvaraj S. Ramakrishnan N, et al. Chronic Stress (Thousand Oaks). 2019 Jul 23;3:2470547019861417. doi: 10.1177/2470547019861417. eCollection 2019 Jan-Dec. Chronic Stress (Thousand Oaks). 2019. PMID: 32440596 Free PMC article. No abstract available.
386 results